Lonza Group AG
Last quote: (Paris time)
Source: Yahoo FinanceDelayed quotesOutdated data
Synthèse : Lonza Group AG
Lonza Group AG (LONN.SW) est cotée sur SIX Swiss Exchange (Europe), dans le secteur Health. Son cours est exprimé en CHF. TimeLinq suit 119 autres valeurs du secteur Health, avec lesquelles cette fiche permet de la comparer.
Sa capitalisation boursière atteint 42.19B CHF. Son PER sur les 12 derniers mois est de 40.0. Sa marge nette ressort à −1.6%. Son rendement du dividende est de 0.83%.
Sur un an, le cours a varié de +9.2%, avec une volatilité annuelle de 23%. Le cours se situe au-dessus de sa moyenne mobile à 200 jours (+13.2%).
Indications calculated automatically from public market data; they do not constitute investment advice.
Price change
Lonza Group AG : de 538.40 CHF à 604.00 CHF over 1 month, soit une variation de +12.18%.
Source: Yahoo FinanceDelayed quotes, Paris time
Key figures
- Previous close
- CHF 603.80
- Day's range
- CHF 597.60 – CHF 606.80
- Volume (shares)
- 170,307
- Listing venue
- SIX Swiss Exchange
- 52-Week Range
- CHF 454.60CHF 608.40
Source: Yahoo FinanceOutdated data
In brief
The key figures, explained simply.
- 1-year performance
- +9.2%Change in share price over the past 12 months.
- Market capitalization
- 42.19B CHFTotal market value of the company.
- P/E (12M)
- 40.0How many years of current earnings the share price represents.
- Net margin
- −1.6%Out of every 100 in sales, what remains as profit.
- Volatility (1 year)
- 23%Typical magnitude of share price moves over one year.
- Dividend yield
- 0.83%Annual dividend relative to the share price.
Fundamental modelThe share price is above the range given by our valuation models (CHF 20.31 – CHF 348.80). See the Valuation tab for assumptions.
Source: Yahoo Finance (données fondamentales)Published accounts, indicative data
Company profile
- Sector
- Health
- Listing venue
- SIX Swiss Exchange
- Region
- Europe
- Quote currency
- CHF
Other companies in the Health sector
Click a company to open its profile, or compare it directly.
| Company | Price | Change | Market capitalization | P/E | Compare |
|---|---|---|---|---|---|
| Novo NordiskNOVO-B.CO | DKK 259.60 | −1.46% | 1.15T DKK | 9.7 | Compare |
| RocheROG.SW | — | — | — | — | Compare |
| NovartisNOVN.SW | CHF 124.70 | −0.95% | 237.02B CHF | 23.8 | Compare |
| AstraZenecaAZN.L | 12,446.00 p | −1.98% | 193.03B £ | 25.8 | Compare |
| GSKGSK.L | 1,862.50 p | −0.32% | 74.63B £ | 15.8 | Compare |
| BayerBAYN.DE | €44.46 | +0.11% | 43.68B € | — | Compare |
| PhilipsPHIA.AS | €23.16 | +1.94% | 22.64B € | 20.1 | Compare |
| FreseniusFRE.DE | €45.08 | +2.78% | 25.39B € | 16.3 | Compare |
| Fresenius Medical CareFME.DE | €39.54 | +0.20% | 10.62B € | 11.9 | Compare |
| MerckMRK.DE | €144.30 | +0.73% | 62.74B € | 26.5 | Compare |
Source: Yahoo FinanceDelayed quotes